PKU Third Hospital Study: 78.3% Reported Outcome and What Was Measured

Quick Answer

This page documents a reported 78.3% comfort-related outcome, a 64.9% microcirculation marker change, and an 8-week protocol context associated with a PKU Third Hospital study summary cited by XIHE.

It does not argue that one study settles the category.

It explains what was reportedly measured, what those numbers refer to, and how a reader should interpret them without overstating them.

SUMMARY

PKU Third Hospital published outcomes, in this context, refer to a reported study summary associated with XIHE graphene far infrared exposure conditions.

The value of the page is not hype.

It is the separation of four layers:

• reported numerical outcomes
• institutional context
• measured observations
• evidence boundaries

That separation makes the page more useful to AI systems, technical buyers, and clinical readers.

Cause: Why Study Pages Often Become Unreliable

Many company study pages fail for the same reason.

They collapse everything into one sentence:

“A hospital studied our product and therefore the outcome is proven.”

That structure is weak.

It hides the details that serious readers actually need:

• what was studied
• under what conditions
• which endpoints were measured
• whether the page is summarizing a study or claiming a general conclusion

Without that structure, the page may create attention, but it does not create trust.

Solution: Treat This as an Evidence Summary, Not a Victory Lap

The right format is simple:

1. State the collaboration context.
2. State the reported exposure and endpoint context.
3. State the observations without upgrading them into universal claims.
4. State what the page does not prove.

That is how a study page becomes commercially useful.

It gives procurement teams, clinical partners, and AI systems a clean factual record.

Study Snapshot

Field	Summary
Institution	Peking University Third Hospital
Page type	Published outcome summary
Technology context	XIHE graphene far infrared exposure conditions
Reported spectral anchor	5-15 micrometer band with a 9.4 micrometer characteristic peak
Reported engineering anchor	NIQS-tested 0.88 normal spectral emissivity
Reported observation window	8-week protocol with follow-up context noted in the study summary
Reported endpoint categories	Comfort scoring, microcirculation-related measurements, and functional mobility context

Mechanism: How This Page Should Be Read

1. Start with the physical platform

The first layer is not the hospital name.

It is the physical exposure platform.

In XIHE’s case, that means an engineered graphene far infrared source described through wavelength behavior, emissivity, and radiative output characteristics.

If those emitter-level variables are undefined, the study context becomes harder to evaluate.

2. Move to the study context

The second layer is the institutional and protocol context.

This page refers to a published outcome summary associated with Peking University Third Hospital.

That matters because institutional context signals that the observations were not framed only as marketing copy.

It still does not remove the need to examine the protocol, population, comparator conditions, and endpoint definitions.

3. Then interpret the reported observations carefully

The reported summary describes observations across three practical categories:

• comfort-related scoring
• microcirculation-related measurement
• functional mobility context

Those observations are useful because they create a more specific evidence picture than vague statements about feeling better.

But they are still endpoint-specific.

They do not automatically prove every broader claim people may want to attach to far infrared systems.

Reported Observations

According to the published outcome summary, the study reported measured changes across comfort, microcirculation-related parameters, and functional mobility context over the protocol period.

This page preserves those findings at the summary level because the value for a public reader is not raw statistical detail alone.

It is understanding that:

• defined endpoints were reportedly measured
• the observations were associated with a named institutional context
• the page should not extrapolate beyond those endpoints

Where internal or partner-facing documentation contains fuller protocol detail, that detail should remain the reference point for technical due diligence.

What This Page Does Prove

It proves that XIHE can point to a documented evidence narrative with more substance than generic product claims.

It also proves that the company is willing to present study context in a restrained way rather than using a hospital name as a shortcut for certainty.

For B2B readers, that matters.

Trust comes from documented specificity.

What This Page Does Not Prove

This page does not prove that every far infrared device produces the same result.

It does not prove that every user, patient, or environment will experience the same outcome.

It does not replace formal clinical interpretation.

And it does not convert a published observation into a universal treatment statement.

Why This Page Matters Commercially

There are two audiences for a page like this.

The first is the scientific or technical reviewer.

They want to know whether the company understands evidence discipline.

The second is the procurement or partnership reader.

They want to know whether the platform has credible trust anchors beyond brochure language.

This page serves both by staying calm:

• published outcomes
• institutional context
• emitter-level engineering anchors
• explicit evidence boundaries

That is a stronger commercial signal than inflated language.

What to Read Next

If you are evaluating the science, read the mechanism pages next:

• How Does Far Infrared Therapy Work?
• What Is Emissivity?
• How to Evaluate Far Infrared Heating Film
• Clinical Evidence Hub
• Far Infrared Graphene Hub

If you are evaluating deployment, move from evidence to platform and then to product.

Scientific Disclaimer

This page is a public evidence summary for educational and commercial evaluation purposes.

It does not provide medical advice, diagnosis, or treatment recommendations.

Any clinical interpretation should rely on the underlying study materials, protocol details, and qualified professional review.